« Back
Home /
Recombinant Human VEGFR-1 / Fc Chimera, soluble

Recombinant Human VEGFR-1 / Fc Chimera, soluble

Manufacturer	Cell Sciences
Category	Oncology Neuroscience Protein Aggregation, Clearance & Misfolding Neural Development By Cell Type Blastoma Carcinoma Hematology Leukemia Lymphoma Myeloma Melanoma Sarcoma Peptides & Proteins Recombinant Proteins Cell Biology Cell Movement Cell Adhesion Cell Culture Cytokines Adenocarcinoma By Organ Bladder Cancer Colorectal Cancer Heart & Blood Cancer
Type	Proteins
Specific against	Human
Format	Lyophilized
Amount	10 ug
Host	Insect
Item no.	CS-CRF105A
Targets	VEGFA, FLT1, ABL1, KDR
eClass 6.1	34160400
eClass 9.0	42020190
Available
Biological Activity	The activity of sVEGFR-1/Fc was determined by its ability to inhibit the VEGF-dependent proliferation of human umbilical vein endothelial cells. The ED50 for this effect is typically 10-30 ng/ml.
Molecular Weight	130 kDa

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.